Add Company
Join Now

Attralus Revenue and Competitors

License our Company Data API

Location

#4327

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Attralus's estimated annual revenue is currently $5.9M per year.(i)
  • Attralus's estimated revenue per employee is $155,000

Employee Data

  • Attralus has 38 Employees.(i)
  • Attralus grew their employee count by 41% last year.

Attralus's People

NameTitleEmail/Phone
1
COO, Co-FounderReveal Email/Phone
2
CEOReveal Email/Phone
3
VP, Head Toxicology, Drug Disposition, and PK/PDReveal Email/Phone
4
SVP, CMCReveal Email/Phone
5
Head IT OperationsReveal Email/Phone
6
SVP Clinical DevelopmentReveal Email/Phone
7
Head Corporate DevelopmentReveal Email/Phone
8
Head Human ResourcesReveal Email/Phone
9
Head Program ManagementReveal Email/Phone
10
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Attralus?

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Attralus News

2022-03-30 - Positive New Data from Phase 1/2 Trial of AT-01 Presented at ...

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with...

2022-03-30 - Positive New Data from Phase 1/2 Trial of AT-01 Presented at 2022 American College of Cardiology Annual Scientific Session

SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M380%N/A
#2
$7.8M386%$200M
#3
$7.4M380%N/A
#4
$7.6M38-14%N/A
#5
$6.2M38-39%N/A